Navigation Links
Standard & Poor's Announces Changes to U.S. Indices
Date:11/11/2008

NEW YORK, Nov. 11 /PRNewswire/ --Standard & Poor's will make the following changes to the S&P 500 and S&P MidCap 400 indices:

-- General Growth Properties Inc. (NYSE Arca: GGP) will be removed from the

S&P 500 after the close of trading on Wednesday, November 12. As of

today's close of trading General Growth Properties had a market

value of approximately $128 million, ranking 500th in the index.

-- S&P MidCap 400 constituent Cephalon Inc. (Nasdaq: CEPH) will be

added to the S&P 500, and Mariner Energy Inc. (NYSE: ME) will

replace Cephalon Inc. in the S&P MidCap 400, after the close of

trading on Friday, November 14. Cephalon is taking the place of

General Growth Properties in the S&P 500.

Standard & Poor's will monitor these transactions, and post any relevant updates on its website: http://www.standardandpoors.com.

Cephalon is a biopharmaceutical developer specializing in products related to the central nervous system, pain, oncology and addiction. Headquartered in Frazer, PA, the company will be added to the S&P 500 GICS (Global Industry Classification Standard) Biotechnology Sub-Industry index.

Mariner Energy is an oil and gas exploration, development and production company operating principally in the Gulf of Mexico and the Permian Basin in West Texas. Headquartered in Houston, TX, the company will be added to the S&P MidCap 400 GICS Oil
'/>"/>

SOURCE Standard & Poor's
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Osteotechs Next Generation Grafting Material, MagniFuse(TM) Bone Graft, a Breakthrough in Bone Regeneration; MagniFuse(TM) Bone Graft seeks to redefine the standard of care in the U.S. bone graft substitute market estimated to be in excess of $1.2 billio
2. SuperGens MP-470 Demonstrates Clinical Tumor Regression When Combined with Standard of Care Chemotherapy
3. GeoVax Labs, Inc. Information To Be Available Through Standard & Poors Market Access Program
4. Oncothyreon announces receipt of NASDAQ letter regarding compliance with NASDAQ Global Market listing standards
5. Masimo Announces Desaturation Index 3D Alarm as Standard Feature in All Radical-7 Pulse CO-Oximetry Devices
6. Mymetics Corporation Information to be Available Through Standard & Poors Market Access Program
7. Oncothyreon announces receipt of notice of non-compliance with market value of listed securities standard for listing on The NASDAQ Global Market
8. Repair Stem Cell Institute Announces Industrys First Standards of Excellence for Global Stem Cell Treatment Centers to Protect Patients from Less-than-Competent Therapeutics
9. Project Mind Survey of Israeli Ph.D. Scientists Favors a New Standard of Creativity in Science
10. Comprehensive Jatropha Standards Mandatory in Optimum Long-term Biofuel Efficacy
11. WuXi AppTec VP and GM Invited to Join the AAMI Standards Board

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)..., QUINCY, Mass., Nov. 6 Myria... biotech developer and manufacturer of renewable ... preferred technology provider Uhde GmbH, one of t...y "Uhde"), announced an alliance for the engineeri...t,s biobased Succinic Acid plants based on renewab...
(Date:11/6/2009)..., HAYWARD, Calif., Nov. 6 Int...ns today on its ITCA 650 (DUROS® continuous d... type 2 diabetes at the Ninth Annual Diabetes Tech... http://www.newscom.com/cgi-bin/prnh/20050301/SFTU... of Exenatide Via ITCA 650 Lowers Plasma Glucose, ...
(Date:11/5/2009)..., PARSIPPANY, N.J., Nov. 5 DS...has made a manufacturing alliance with Galenix, Sa...eferred commercial scale manufacturing partner for..., DSM and Galenix will collaborate on business d... delivery technologies, based on the strength of G...
(Date:11/5/2009)..., LYNBROOK, N.Y., Nov. 5 /PRNewswire-FirstCal...TC ), a biopharmaceutical company developing first...ced its financial results for the third quarter en...happy that, in September of this year, the FDA,s A...d, by a vote of 12-0, the approval of XIAFLEX(TM) ...
Breaking Biology Technology:Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 2Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 4Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 5DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 2DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 3BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5
... Codexis, Inc. today announced,a licensing agreeme...oduce an,important publicly-undisclosed generic pr...eva, the largest generic drug manufacturer in the ...ct. The product is one of the largest-,selling ge... Under the agreement, Teva would be using the Co...
...tradigm Corporation, a leading,developer of target... today,announced that the company has closed the f...enture Management led the $2.9 million tranche, wi...pating. The addition of these,funds brings the to...m will,use Series B funds to advance its RNAi ther...
...s, Inc. (Nasdaq: ABAX ), a medical products comp...truments for both the medical and veterinary marke...ense agreement for co-exclusive worldwide rights i...ofessional marketplace for certain technologies pe...ethods. , , This license agreement provides Abaxi...
Other Biology Technology:Codexis, Teva in Licensing Agreement Final 2Intradigm Closes Final Tranche of $21.4 Million Series B Financing 2Intradigm Closes Final Tranche of $21.4 Million Series B Financing 3ABAXIS Announces Worldwide Animal Health Licensing Agreement for Rapid Test Technology 2ABAXIS Announces Worldwide Animal Health Licensing Agreement for Rapid Test Technology 3
(Date:11/4/2009)...ence) , United States Using Less Water Today ...t did 35 years ago, despite a 30 percent populatio...butable to alternative cooling methods at power pl...ing to the latest USGS water use report, nearly ha...cooling thermoelectric power plants. Irrigation ac...
(Date:11/4/2009)...an has received more than $10 million in research ...ederal stimulus program, bringing thetotal amount ...$23 million. Thirty-three projects achieved stimu...o weather. , "The university has thoughtfully un... scholarly excellence to federal agency priorities...
(Date:11/4/2009)...re/ -- What,s the cost of saving a teenage life? W...ing from prescription medication abuse, there,s no... may be unaware that the lock-boxes they,ve instal...g timebomb of prescription drugs. That,s why MEDNE...l supplies, has formed an exclusive partnership wi...
Breaking Biology News(10 mins):USGS science picks 2USGS science picks 3USGS science picks 4USGS science picks 5USGS science picks 6USGS science picks 7OU achieves $10 million in stimulus grants for 33 projects on the Norman campus 2OU achieves $10 million in stimulus grants for 33 projects on the Norman campus 3MEDNET Launches MedSafe to Prevent Teenage Prescription Drug Abuse 2MEDNET Launches MedSafe to Prevent Teenage Prescription Drug Abuse 3Country United symposium explores collaborative future of military medicine 58428 1Country United symposium explores collaborative future of military medicine 58428 2Country United symposium explores collaborative future of military medicine 58428 3Critical Zone Observatory seeks to answer climate change questions 10146 1Critical Zone Observatory seeks to answer climate change questions 10146 2Critical Zone Observatory seeks to answer climate change questions 10146 3Critical Zone Observatory seeks to answer climate change questions 10146 4Dr Richard Feinman to speak on the science of diabetes and diet on Oct 2 10142 1
...l known that the bodys energy levels cycle on a 24...olic process is fueled by oxygen. Now, researchers...ine have found that a protein called Rev-erb coord...lecules to maintain the bodys correct metabolism. ...ce Express in advance of print publication in Scie...
...ers at Cincinnati Childrens have issued the first ...blood clotting (fibrin), also plays an important r...f rheumatoid arthritis. Inflammatory joint disease...atory cells with fibrin matrices through a specifi... issue of The Journal of Clinical Investigation, r...
... heck of a commute., The record holder in the Pac...as tagged in the Clearwater River, Idaho, in April...the southern Kuril Islands near Japan. The most di...lies, as they say is 4,200 miles. Imagine fish th...ck to their home streams in order to spawn., The ...
Other Biology News:A mechanism to explain biological 'cross-talk' between 24-hour body cycle and metabolism 2Blood clotting protein linked to rheumatoid arthritis 2UW launches cutting-edge DNA 'fin-printing' project for salmon 2UW launches cutting-edge DNA 'fin-printing' project for salmon 3
...)-HODE-d4 contains 4 deuterium atoms at the 9, 10,...n internal standard for the quantification of 13(S...is produced by incubation of linoleic acid with pl... to inhibit the adhesion of tumor cells to the end...
Adaptor BamH I-Sma I from Takara Mirus Bio
Adaptor Sal I - Sma I from Takara Mirus Bio
Cassette, Sal I from Takara Mirus Bio
Biology Products: